DAVID ANDREW TAUB M.D. NPI 1891804696

NPI Details

David Andrew Taub, M.D. is an urology in Boca Raton, FL with 25 years of experience. The provider is a urologist manages benign and malignant medical and surgical disorders of the genitourinary system and the adrenal gland. This specialist has comprehensive knowledge of and skills in endoscopic, percutaneous and open surgery of congenital and acquired conditions of the urinary and reproductive systems and their contiguous structures. David Andrew Taub, M.D. NPI is 1891804696. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE
Graduation Year:2000

The provider's business location address is:

701 NW 13TH ST
THIRD FLOOR
BOCA RATON, FL
ZIP 33486-305
Phone: (561) 955-5790
Fax: (561) 955-5791

The NPI 1891804696 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Ultrasound measurement of bladder capacity after voiding (HCPCS:51798)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Automated urinalysis test (HCPCS:81003)
• Diagnostic exam of bladder and urethra using an endoscope (HCPCS:52000)
• Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Injection, garamycin, gentamicin, up to 80 mg (HCPCS:J1580)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Leuprolide acetate (for depot suspension), 7.5 mg (HCPCS:J9217)
• Destruction of growth of bladder and urethra using an endoscope, less than 0.5 cm (HCPCS:52224)
• Initial hospital inpatient care per day, typically 50 minutes (HCPCS:99222)
• Follow-up hospital inpatient care per day, typically 15 minutes (HCPCS:99231)
• New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
• Ultrasonic guidance for needle placement (HCPCS:76942)
• Biopsy of prostate gland (HCPCS:55700)
• Ultrasound scan of pelvic region through rectum (HCPCS:76872)
• Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
• 3d radiographic procedure with computerized image postprocessing (HCPCS:76377)
• New patient office or other outpatient visit, 30-44 minutes (HCPCS:99203)
• Insertion of stent in ureter using an endoscope (HCPCS:52332)
• Removal of lymph nodes of both sides of pelvis using an endoscope (HCPCS:38571)
• Dilation of urethra using an endoscope (HCPCS:52281)
• Surgical removal of prostate and surrounding lymph nodes using an endoscope (HCPCS:55866)
• Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope (HCPCS:52310)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Destruction and/or removal of growth of bladder and urethra using an endoscope, 2.0-5.0 cm (HCPCS:52235)
• Partial removal of kidney using an endoscope (HCPCS:50543)
• Ultrasound scan of pelvic region through rectum (HCPCS:76872)
• Biopsy of prostate gland (HCPCS:55700)
• Prostate resection (HCPCS:NAN14)

The enumeration date for this NPI number is 8/29/2006 and was last updated on 4/25/2017.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.